Last updated: 20 July 2019 at 2:44am EST

Capital Management, Llcaldr... Net Worth




The estimated Net Worth of Capital Management, Llcaldr... is at least $65.7 Million dollars as of 17 November 2008. Capital Llcaldr owns over 44,887 units of Biospecifics Technologies stock worth over $65,706,612 and over the last 16 years Capital sold BSTC stock worth over $0.

Capital Llcaldr BSTC stock SEC Form 4 insiders trading

Capital has made over 3 trades of the Biospecifics Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently Capital bought 44,887 units of BSTC stock worth $748,715 on 17 November 2008.

The largest trade Capital's ever made was buying 44,887 units of Biospecifics Technologies stock on 17 November 2008 worth over $748,715. On average, Capital trades about 21,994 units every 18 days since 2008. As of 17 November 2008 Capital still owns at least 742,196 units of Biospecifics Technologies stock.

You can see the complete history of Capital Llcaldr stock trades at the bottom of the page.



Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo und Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.





What does Biospecifics Technologies's logo look like?

Biospecifics Technologies Corp. logo

Complete history of Capital Llcaldr stock trades at Biospecifics Technologies

Datum
#
Unternehmen
Insider
Trans.
Transaktion
Anzahl der Aktien Preis je Aktie Gesamtpreis Anzahl der Aktien nach Quelle
17 Nov 2008 Capital Management, Llcaldr...
Kauf 44,887 $16.68 $748,715
17 Nov 2008
742,196
6 Oct 2008 Capital Management, Llcaldr...
Kauf 6,900 $15.83 $109,227
6 Oct 2008
636,444
24 Sep 2008 Capital Management, Llcaldr...
Kauf 14,196 $18.49 $262,484
24 Sep 2008
629,544


Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include: